Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma
Authors:
Open Access
- 24 January 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e85592
Abstract
Protein tyrosine phosphatase non-receptor type 12 (PTPN12), has been identified as a potent tumor suppressor in human cancers and a critical regulator of cell adhesion and migration. However, the PTPN12 expression and its prognostic significance in HCC have not been well elucidated. In this study, tissue microarray-based immunohistochemistry (IHC) was investigated in an HCC cohort with adjacent liver tissues as controls. The resulting data were analyzed using receiver operating characteristic curves, Spearman's rank correlation, Kaplan-Meier plots and Cox proportional hazards regression modeling. Our results showed that decreased expression of PTPN12 was more frequently observed in HCC tissues compared to the adjacent non-tumorous liver tissues. Further correlation analyses indicated that the decreased PTPN12 expression was closely correlated with tumor recurrence (P = 0.015). Univariate analysis showed a significant association between decreased expression of PTPN12 and adverse cancer-specific survival and recurrence-free survival (PPP<0.05) identified PTPN12 expression in HCC as an independent prognostic factor. Our findings provide a basis for the concept that PTPN12 protein expression is frequently decreased or lost in human HCC tissues and that decreased PTPN12 expression may represent an acquired recurrence phenotype of HCC and that PTPN12 expression may act as a biomarker of prognosis for patients with HCC.Keywords
This publication has 30 references indexed in Scilit:
- Ras-Induced and Extracellular Signal-Regulated Kinase 1 and 2 Phosphorylation-Dependent Isomerization of Protein Tyrosine Phosphatase (PTP)-PEST by PIN1 Promotes FAK Dephosphorylation by PTP-PESTMolecular and Cellular Biology, 2011
- EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsiesGut, 2011
- PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cellsAmerican Journal of Physiology-Cell Physiology, 2010
- Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinomaCancer Science, 2010
- Tyrosine phosphorylation: thirty years and countingCurrent Opinion in Cell Biology, 2009
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- PTP-PEST phosphatase variations in human cancerCancer Genetics and Cytogenetics, 2006
- The molecular pathogenesis of hepatocellular carcinomaJournal of Viral Hepatitis, 1994